Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
STAT-Dx logo — company profile

STAT-Dx

Founded 2010 18 employees Series C Total: $49.10M Biotechnology, Health Care

General Information

Company Name STAT-Dx
Founded Year 2010
Employees 18
Industries Biotechnology, Health Care
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with STAT-Dx. To contact STAT-Dx, visit stat-dx.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does STAT-Dx compare?

A PDF of STAT-Dx and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting STAT-Dx soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About STAT-Dx

STAT-Dx is a biotechnology and healthcare company founded in 2010. The company's mission is to support timely, efficient patient care while optimizing laboratory and hospital processes and operations. They believe in fast syndromic testing to move innovative diagnostics closer to care. The latest investment of €25.00M was made during the Series C - STAT round on 10 April 2016. The investment was led by a consortium of prominent investors including Caixa Capital Risc, IDInvest Partners, Kurma Partners, Next47, Gilde Healthcare, BIVF, Ysios Capital, and AXIS Telekom. STAT-Dx aims to make a difference in healthcare by leveraging innovative technologies. To learn more about their work, visit their website at www.stat-dx.com.

Taxonomy: molecular diagnostics, syndromic testing, real-time PCR, point-of-care testing, infectious disease diagnostics, hospital operations, laboratory processes, clinical diagnostics

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C Stat €25.00M 8
Caixa Capital Risc IDInvest Partners Kurma Partners
Caixa Capital Risc, IDInvest Partners +6
10 Apr 2016
Series B Stat €22.10M 2
IDInvest Partners Ysios Capital
IDInvest Partners, Ysios Capital
06 May 2013
Series A Stat €2.00M -
16 Jun 2011

STAT-Dx Alternatives & Competitors

View All Alternatives
STAT-Dx vs
Xagenic
Xagenic

Empowering clinicians with rapid, near-patient molecular testing for improved patient care and reduc...

Series B
Biotechnology, Health Care
STAT-Dx vs
Senzo Health
Senzo Health United States

PCR-Accurate Lateral Flow Testing

8 employees
Biotechnology, Health Care
STAT-Dx vs
Paratus Diagnostics
Paratus Diagnostics United States

Advancing Diagnostic Technology

Venture round
3 employees
Biotechnology, Health Care
View all alternatives

FAQ About STAT-Dx

Our Mission is to Support Timely, Efficient Patient Care, while Optimizing Laboratory and Hospital Processes & Operations. At STAT-Dx we believe in Fast Syndromic Testing to move innovative diagnostics Closer to Care. Make a difference in healthcare and join us! www.stat-dx.com
STAT-Dx was founded in 2010.
STAT-Dx operates in Biotechnology and Health Care. Its work centres on molecular diagnostics, syndromic testing, real-time PCR and point-of-care testing.
STAT-Dx has approximately 18 employees.
STAT-Dx has completed 3 funding rounds, raising a total of $49.10M. The latest funding stage is Series C.
Top alternatives and competitors to STAT-Dx include Xagenic, Senzo Health, Paratus Diagnostics, FRIZ Biochem GmbH, IMMY. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
STAT-Dx and Xagenic are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for STAT-Dx, https://bouncewatch.com/company/stat-dx, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes